Tag: Belite Bio

Manufacturing, Research and Development

How Belite Bio, a small, under-the-radar drugmaker, emerged as one of biotech’s best performing IPOs

August 2, 2022

Via: Biopharma Dive

Biotechnology startups are under pressure. After years of plentiful funding, few young drug companies are going public, and those that do are struggling to hold onto their value in a market downturn that’s forcing biotech executives and their venture backers […]

Clinical Trials, Research and Development

Belite Bio Announces Positive Results from Phase 1 Clinical Trials of LBS-008

July 20, 2020

Via: BioSpace

Belite Bio, LLC, a clinical-stage biotech company, today announced positive results from two Phase 1 clinical trials in the United States and Australia for LBS-008, a First-in-Class oral small molecule Retinol Binding Protein 4 (RBP4) specific antagonist aimed to treat […]